iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership18,467 shares
Latest Disclosed Value $ 3,118,191
Pinnacle Associates Ltd reports 0.61% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 18,467 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $3,118,191 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 18,581 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.61% during the quarter. The current value of the position is $2,420,100 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,467 -114 -0.61 3,118 -0.54 0.0400
2026-02-05 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,581 4,887 35.69 3,136 58.65 0.0402
2025-11-13 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,694 -224 -1.61 1,977 12.27 0.0262
2025-08-04 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,918 -1,379 -9.01 1,761 -10.02 0.0255
2025-05-06 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,297 -78 -0.51 1,957 -3.74 0.0287
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,375 1,819 13.42 2,033 10.37 0.0276
2024-10-25 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,556 359 2.72 1,842 1.66 0.0313
2024-07-30 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,197 -200 -1.49 1,811 -1.47 0.0284
2024-04-26 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,397 -159 -1.17 1,838 -0.16 0.0290
2024-01-19 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,556 108 0.80 1,842 11.98 0.0310
2023-10-24 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,448 -365 -2.64 1,645 -6.22 0.0306
2023-07-27 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,813 2,715 24.46 1,754 22.33 0.0304
2023-05-05 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,098 307 2.84 1,433 1.20 0.0293
2023-02-01 2022-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 10,791 210 1.98 1,417 14.38 0.0309
2023-01-25 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,706 125 1,433 0.0000
2022-11-01 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,581 270 2.62 1,238 2.06 0.0284
2022-08-02 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,311 -1,510 -12.77 1,213 -21.23 0.0265
2022-05-05 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,821 -39,431 -76.94 1,540 -80.31 0.0273
2022-02-02 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 51,252 165 0.32 7,822 -5.30 0.1349
2021-10-19 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 51,087 -3,335 -6.13 8,260 -7.25 0.1523
2021-08-02 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 54,422 13,170 31.93 8,906 43.39 0.1610
2021-05-12 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 41,252 -5,895 -12.50 6,211 -13.04 0.1184
2021-01-26 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 47,147 -820 -1.71 7,142 9.96 0.1450
2020-10-23 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 47,967 -5 -0.01 6,495 -0.95 0.1543
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 47,972 -3,064 -6.00 6,557 19.24 0.1617
2020-05-13 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 51,036 112 0.22 5,499 -10.40 0.1670
2020-02-03 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 50,924 175 0.34 6,137 21.52 0.1344
2019-11-08 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 50,749 -20,518 -28.79 5,050 -35.05 0.1190
2019-08-05 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 71,267 3,475 5.13 7,775 2.59 0.1821
2019-05-10 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 67,792 -4,506 -6.23 7,579 8.71 0.1712
2019-02-05 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 72,298 -76 -0.11 6,972 -21.00 0.1800
2018-11-09 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 72,374 -3,982 -5.22 8,825 5.25 0.1831
2018-08-08 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 76,356 -5,416 -6.62 8,385 -3.93 0.1725
2018-05-11 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 81,772 -12,306 -13.08 8,728 -13.11 0.1710
2018-02-12 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 94,078 64,043 213.23 10,045 0.26 0.1930
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 30,035 -835 -2.70 10,019 4.67 0.1847
2017-08-09 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 30,870 -385 -1.23 9,572 4.43 0.1840
2017-05-09 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 31,255 1,540 5.18 9,166 16.23 0.1750
2017-02-10 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 29,715 27,745 1,408.38 7,886 1,283.51 0.1591
2016-11-14 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,970 -415 -17.40 570 -7.17 0.0114
2016-08-15 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 2,385 904 61.04 614 59.07 0.0132
2016-05-13 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,481 -1,647 -52.65 386 -63.52 0.0083
2016-02-11 2015-12-31 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 3,128 1,628 108.53 1,058 132.53 0.0222
2016-02-09 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 3,128 1,628 1,058 0.0226
2015-11-10 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,500 600 66.67 455 37.05 0.0101
2015-08-12 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 900 900 0.00 332 0.0062
2015-05-15 2015-03-31 13F iShares Nasdaq Biotechnology ETF 464287556 0 -675 -100.00 0 -100.00
2015-02-12 2014-12-31 13F iShares Nasdaq Biotechnology ETF 464287556 675 675 0.00 205 0.0040
2014-11-12 2014-09-30 13F iShares Nasdaq Biotechnology ETF 464287556 0 -3,125 -100.00 0 -100.00
2014-08-14 2014-06-30 13F iShares Nasdaq Biotechnology ETF 464287556 3,125 1,800 135.85 803 166.78 0.0157
2014-02-12 2013-12-31 13F iShares Nasdaq Biotechnology ETF 464287556 1,325 -200 -13.11 301 -5.94 0.0059
2013-11-14 2013-09-30 13F iShares Nasdaq Biotechnology ETF 464287556 1,525 50 3.39 320 25.00 0.0066
2013-08-13 2013-06-30 13F iShares Nasdaq Biotechnology ETF 464287556 1,475 1,475 256 0.0058
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.